Glen Eagle Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-75
Closed -$4.96K 1136
2024
Q3
$4.96K Hold
75
﹤0.01% 761
2024
Q2
$4.55K Hold
75
﹤0.01% 766
2024
Q1
$4.27K Hold
75
﹤0.01% 795
2023
Q4
$4.71K Buy
+75
New +$4.24K ﹤0.01% 746
2020
Q2
Sell
-125
Closed -$9.15K 922
2020
Q1
$9.15K Buy
+125
New +$9.44K 0.01% 527
2019
Q2
Sell
-15
Closed -$1.29K 804
2019
Q1
$1.29K Hold
15
﹤0.01% 688
2018
Q4
$954 Sell
15
-9
-38% -$584 ﹤0.01% 674
2018
Q3
$1.66K Hold
24
﹤0.01% 642
2018
Q2
$1.61K Sell
24
-100
-81% -$6.84K ﹤0.01% 625
2018
Q1
$10.3K Buy
124
+10
+9% +$902 0.01% 434
2017
Q4
$10.8K Buy
+114
New +$11.9K 0.01% 419

Other funds holding INCY

Glen Eagle Advisors's INCY Position: Q4 2024 in Review

Glen Eagle Advisors sold out of Incyte (INCY) in Q4 2024, closing a stake of 75 shares — an estimated $4.96K sold.

Glen Eagle Advisors first reported a position in INCY in Q4 2017 and held it in 11 quarters. The position peaked at $10.8K in Q4 2017. 649 funds tracked by Wall St. Rank hold INCY as of Q4 2024.

  • Glen Eagle Advisors reported no remaining Incyte position as of Q4 2024 after selling out during the quarter.
  • Glen Eagle Advisors sold 75 Incyte shares in Q4 2024, an estimated $4.96K.
  • Glen Eagle Advisors first reported a position in Incyte in Q4 2017 and held it in 11 quarters.
  • Glen Eagle Advisors's Incyte position peaked at $10.8K in Q4 2017.
  • 649 funds tracked by Wall St. Rank held Incyte as of Q4 2024.

Based on Glen Eagle Advisors's 13F filing for Q4 2024, filed 18 Feb 2025.